Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01). Shamseddine A, Abbas N, Temraz S, Al Darazi M, et al. Future Oncol 2025;21:3873-3884.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shamseddine A, Abbas N, Temraz S, Al Darazi M, et al. Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01). Future Oncol 2025;21:3873-3884.
PMID: 40851456